Concepedia

Publication | Closed Access

Adjuvant Systemic Chemotherapy with or without Bevacizumab in Patients with Resected Liver Metastases from Colorectal Cancer

24

Citations

18

References

2012

Year

Abstract

Chemotherapy type and addition of BEV have no impact on both RFS and OS in the adjuvant setting following complete resection of colorectal liver metastases.

References

YearCitations

Page 1